CRVO · NASDAQ
CervoMed (CRVO) Stock Price & Fundamentals
CervoMed (CRVO) closed at $864.37 on Oct 9, 2026, up 0.45% from the previous close of $860.54.
Share price, past year
1Y +9.04%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $864.37 |
| Sep 30, 2026 | $841.25 |
| Aug 31, 2026 | $842.07 |
| Jul 31, 2026 | $876.70 |
| Jun 30, 2026 | $852.53 |
| May 29, 2026 | $846.24 |
| Apr 30, 2026 | $835.55 |
| Mar 31, 2026 | $826.93 |
| Feb 27, 2026 | $824.51 |
| Jan 30, 2026 | $794.90 |
| Dec 31, 2025 | $780.69 |
| Nov 28, 2025 | $744.44 |
| Oct 31, 2025 | $807.58 |
Key statistics
- Market cap
- $11.69B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $331.30K
- Net income (TTM)
- −$30.35M
- Shares outstanding
- 13.5M
- Dividend yield
- —
- 52-week range
- $744.44 – $900.66
CervoMed's market cap is $11.69B, based on a share price of $864.37 and 13.5M shares outstanding as of Jun 30, 2026.
Financials
CervoMed reported revenue of $4.01M for fiscal 2025, down 58.86% from fiscal 2024.
CervoMed reported a net loss of $26.97M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $4.01M | −58.9% | −$26.97M | −673.1% | — | — |
| FY2024ended Dec 31, 2024 | $9.74M | +36.3% | −$16.29M | −167.3% | — | — |
| FY2023ended Dec 31, 2023 | $7.14M | — | −$2.17M | −30.4% | — | — |
| FY2022ended Dec 31, 2022 | $0.00 | −100.0% | −$5.80M | — | $2,038,891.00 | — |
| FY2013ended Dec 31, 2013 | $71.67K | −80.9% | — | — | −$1.00 | — |
| FY2012ended Dec 31, 2012 | $374.54K | −34.4% | — | — | — | — |
| FY2011ended Dec 31, 2011 | $570.48K | +1,319.5% | — | — | — | — |
| FY2010ended Dec 31, 2010 | $40.19K | — | — | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $0.00 | −$6.57M | — |
| Q1 FY2026ended Mar 31, 2026 | $0.00 | −$7.96M | — |
| Q4 FY2025ended Dec 31, 2025 | $8.73K | −$8.09M | — |
| Q3 FY2025ended Sep 30, 2025 | $322.57K | −$7.73M | — |
| Q2 FY2025ended Jun 30, 2025 | $1.76M | −$6.26M | — |
| Q1 FY2025ended Mar 31, 2025 | $1.92M | −$4.89M | — |
| Q4 FY2024ended Dec 31, 2024 | $2.16M | −$6.71M | — |
| Q3 FY2024ended Sep 30, 2024 | $1.94M | −$4.75M | −$0.55 |
Company profile
- Name
- CervoMed Inc.
- Ticker
- CRVO
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 20 Park Plaza, Suite 424, Boston, MA 02116
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001053691
Recent SEC filings
- Sep 28, 2026
- Sep 10, 2026
- Aug 10, 2026
- Aug 7, 2026
- Aug 4, 2026
- Jul 14, 2026
- Jul 9, 2026
- Jun 22, 2026
Frequently asked questions
What is CervoMed's stock price?
CervoMed (CRVO) closed at $864.37 on Oct 9, 2026, up 0.45% from the previous close of $860.54.
What is CervoMed's market cap?
CervoMed's market cap is $11.69B, based on a share price of $864.37 and 13.5M shares outstanding as of Jun 30, 2026.
How much revenue does CervoMed make?
CervoMed reported revenue of $4.01M for fiscal 2025, down 58.86% from fiscal 2024.
Does CervoMed pay a dividend?
CervoMed's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from CervoMed Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures